fda news - Search News

FDA Approves 1st New Schizophrenia Drug in Decades

FDA Approves New Kind of Drug for Schizophrenia

FRIDAY, Sept. 27, 2024 (HealthDay News) -- The first new type of medication in decades to help fight against schizophrenia was approved on Thursday by the U.S. Food and Drug Administration.

Reuters on MSN · 3h

Bristol Myers wins US FDA approval for new type of schizophrenia drug

The U.S. Food and Drug Administration approved Bristol Myers Squibb's schizophrenia drug late on Thursday, making it the first new type of antipsychotic medicine in decades. The labeling information of the treatment,

Gizmodo · 1h

FDA Approves Potentially Groundbreaking Schizophrenia Drug

On Thursday, the Food and Drug Administration approved Cobenfy, a drug from Bristol Myers Squibb—the first truly novel treatment for schizophrenia in decades.

Sanofi, FDA and Dupixent

Hosted on MSN · 2h

Sanofi-Regeneron's Dupixent wins FDA's nod for 'smoker's lung'

The U.S. Food and Drug Administration has approved Sanofi and Regeneron's blockbuster drug Dupixent for patients with a chronic lung disease, commonly known as "smoker's lung", the companies said on Friday.

The Wall Street Journal on MSN · 2h

Regeneron, Sanofi Get FDA OK for Dupixent to Treat COPD

Regeneron Pharmaceuticals and Sanofi have won FDA expanded approval of their blockbuster anti-inflammatory drug Dupixent in chronic obstructive pulmonary disease.

Detroit News · 1h

Sanofi blockbuster drug wins clearance in US for lung disease

Sanofi’s Dupixent has been cleared for a chronic lung disorder in the US, in another milestone for the blockbuster drug after a similar decision by European regulators.

Pfizer, FDA and Oxbryta

Hosted on MSN · 10h

FDA alerts patients about Pfizer's Oxbryta withdrawal

The U.S. Food and Drug Administration on Thursday alerted patients and healthcare professionals about the withdrawal of Pfizer's sickle cell disease treatment Oxbryta. Pfizer said late on Wednesday it was pulling the drug from all markets due to risk of a painful complication and death.

STAT · 21h

What the withdrawal of its sickle cell drug means for Pfizer, patients, and the FDA

European regulators on Thursday also said that patients in the trials had higher rates of the pain crises that are hallmarks of sickle cell disease once they started on Oxbryta, also called voxelotor,

Wall Street Journal · 1d

Pfizer to Withdraw Sickle Cell Drug Oxbryta Lots from World-Wide Markets

The healthcare company said clinical data indicates the overall benefit of Oxbryta no longer outweighs the risk in the approved sickle cell patient population.

FDA Lifts Clinical Hold On BMF-219

Reuters on MSN · 22h

US FDA lifts clinical hold on Biomea's diabetes trials

Biomea Fusion said on Thursday the U.S. Food and Drug Administration lifted a clinical hold on ongoing studies of its experimental drug for type 1 and 2 diabetes, sending its shares up 6.9%. The decision comes as a boon for the company as the regulator placed a hold on two trials of its lead drug,

Business Insider · 21h

FDA Lifts Clinical Hold on BMF-219 in Type 2 and Type 1 Diabetes Trials

We greatly appreciate FDA’s review of our data, and the swift resolution of the clinical trial hold. The in-depth review of the clinical data to date reconfirms our confidence in BMF-219 as a novel, first-in-class agent for the treatment of diabetes.

MarketWatch · 23h

Biomea Fusion: FDA Lifts Hold on Diabetes-Treatment Trials

Biomea Fusion said the Food and Drug Administration lifted its clinical hold on continuing clinical trials of the company's diabetes drug. The FDA in June put the biopharmaceutical company's trials on hold,

MedPage Today1h

COVID Preventive Drug Should Work Against Circulating Variants, FDA Now Says

The FDA has determined that the monoclonal antibody pemivibart (Pemgarda) is likely to be effective against currently ...

21h

FDA issues recall notices for two brands of pet food over salmonella and listeria contamination

Pet owners are advised to throw away the at-risk products safely, so pets and children can't access and ingest them ...

FDA Approves New Schizophrenia Drug in 70-Year First

The treatment offers hope to thousands of patients who do not respond to existing medications, and has shown promise in treating other neurological disorders.

BlackDoctor1h

Got Dense Breasts? Here’s What the FDA’s New Rule Means for You!

The U.S. Food and Drug Administration (FDA) passed a critical mandate regarding dense breast tissue. Here's what it means for ...

16h

FDA approves new schizophrenia drug

The U.S. Food and Drug Administration has approved a new drug for adults with schizophrenia, the FDA announced Thursday.

FDA Warns Recalled Dog Food Should Be 'Thrown Out or Destroyed'

The pet food was found to be contaminated with bacteria that can cause illness and even death in pets and humans.

Medscape2h

FDA OKs First-in-Class Antipsychotic for Schizophrenia

The FDA has approved a first-in-class antipsychotic that targets cholinergic receptors without blocking dopamine receptors.

Severity of various FDA product recalls including Class I which can cause death, serious illness

Hundreds of foods are recalled by the FDA every year. Food recalls could fall into different categories, depending on how ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results

Related topics